{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:29:58Z","timestamp":1770751798985,"version":"3.50.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:00:00Z","timestamp":1311638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11657-011-0063-y","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T13:03:30Z","timestamp":1311599010000},"page":"179-188","source":"Crossref","is-referenced-by-count":58,"title":["Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model"],"prefix":"10.1007","volume":"6","author":[{"given":"Aline","family":"Gauthier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet E.","family":"Compston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Borgstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646\u2013650","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"63_CR2","unstructured":"World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series no. 843. World Health Organization, Geneva, pp 1\u2013129"},{"key":"63_CR3","unstructured":"Kanis JA; on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517\u2013522","journal-title":"Bone"},{"key":"63_CR5","volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"Department of Health and Human Services","year":"2004","unstructured":"Department of Health and Human Services (2004) Bone Health and Osteoporosis: A Report of the Surgeon General. Department of Health and Human Services, Washington"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3\u2013S11","journal-title":"Am J Obstet Gynecol"},{"issue":"6914","key":"63_CR7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/bmj.307.6914.1248","volume":"307","author":"GS Keene","year":"1993","unstructured":"Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures. BMJ 307(6914):1248\u20131250","journal-title":"BMJ"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S8756-3282(03)00061-9","volume":"32","author":"JA Kanis","year":"2003","unstructured":"Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK (2003) The components of excess mortality after hip fracture. Bone 32:468\u2013473","journal-title":"Bone"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00198-003-1516-y","volume":"15","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15:108\u2013112","journal-title":"Osteoporos Int"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3111\/200104051062","volume":"4","author":"R Burge","year":"2001","unstructured":"Burge R, Worley D, Johansen A, Bhattacharyya S, Bose U (2001) The cost of osteoporotic fractures in the UK: projections for 2000\u20132020. J Med Econ 4:51\u201362","journal-title":"J Med Econ"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0020-1383(97)00144-7","volume":"28","author":"A Johansen","year":"1997","unstructured":"Johansen A, Evans RJ, Stone MD, Richmond PW, Lo SV, Woodhouse KW (1997) Fracture incidence in England and Wales: a study based on the population of Cardiff. Injury 28:655\u2013660","journal-title":"Injury"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00198-010-1358-3","volume":"22","author":"A Gauthier","year":"2011","unstructured":"Gauthier A, Kanis JA, Martin M, Compston J, Borgstr\u00f6m F, Cooper C, McCloskey E (2011) Development and validation of a disease model for postmenopausal osteoporosis. Osteoporos Int 22:771\u2013780","journal-title":"Osteoporos Int"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1359\/jbmr.1997.12.1.16","volume":"12","author":"LJ Melton 3rd","year":"1997","unstructured":"Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, Johnston CC et al (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12:16\u201323","journal-title":"J Bone Miner Res"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417\u2013427","journal-title":"Osteoporos Int"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382","journal-title":"Bone"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"AC Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468\u2013489","journal-title":"Osteoporos Int"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Lansman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254\u20131259","journal-title":"BMJ"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s001980070064","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C et al (2000) Long-term risk of osteoporotic fracture in Malm\u00f6. Osteoporos Int 11:669\u2013674","journal-title":"Osteoporos Int"},{"key":"63_CR20","unstructured":"Office for National Statistics, General Register Office for Scotland, and Northern Ireland Statistics and Research Agency. http:\/\/www.statistics.gov.uk . Accessed 26 October 2007"},{"key":"63_CR21","unstructured":"Government Actuary\u2019s Department, Projections database: 2006-based principal projections. http:\/\/www.gad.gov.uk\/Demography%20Data\/Population\/index.aspx?y=2006&v=Principal . Accessed 20 October 2010"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1302\/0301-620X.80B2.7762","volume":"80","author":"BR Singer","year":"1998","unstructured":"Singer BR, McLauchlan GJ, Robinson CM, Christie J (1998) Epidemiology of fractures in 15,000 adults: the influence of age and gender. J Bone Joint Surg Br 80:243\u2013248","journal-title":"J Bone Joint Surg Br"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.14236\/jhi.v12i3.120","volume":"12","author":"S Lusignan De","year":"2004","unstructured":"De Lusignan S, Valentin T, Chan T, Hague N, Wood O, van Vlymen J, Dhoul N (2004) Problems with primary care data quality: osteoporosis as an exemplar. Inform Prim Care 12:147\u2013156","journal-title":"Inform Prim Care"},{"key":"63_CR24","doi-asserted-by":"crossref","unstructured":"NICE (National Institute for Clinical Excellence) (2008) Final appraisal determination. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. London. www.nice.org.uk . Accessed 16 November 2010","DOI":"10.1016\/j.bone.2007.10.020"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9220","volume":"9","author":"M Stevenson","year":"2005","unstructured":"Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J (2005) A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess 9:1\u2013160","journal-title":"Health Technol Assess"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2007.10.019","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Adams J, Borgstrom F, Cooper C, Jonsson B, Preedy D, Selby P, Compston J (2008) The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42:4\u201315","journal-title":"Bone"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/bmj.300.6733.1173","volume":"300","author":"TD Spector","year":"1990","unstructured":"Spector TD, Cooper C, Lewis AF (1990) Trends in admissions for hip fracture in England and Wales, 1968\u201385. BMJ 300:1173\u20131174","journal-title":"BMJ"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/pubmed\/23.1.11","volume":"23","author":"S Balasegaram","year":"2002","unstructured":"Balasegaram S, Majeed A, Fitz-Clarence H (2002) Trends in hospital admissions for fractures of the hip and femur in England, 1989\u20131990 to 1997\u20131998. J Public Health Med 23:11\u201317","journal-title":"J Public Health Med"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00198-007-0534-6","volume":"19","author":"A Icks","year":"2008","unstructured":"Icks A, Haastert B, Wildner M, Becker C, Meyer G (2008) Trend of hip fracture incidence in Germany 1995\u20132004: a population-based study. Osteoporos Int 19:1139\u20131145","journal-title":"Osteoporos Int"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1359\/jbmr.060815","volume":"21","author":"P Kannus","year":"2006","unstructured":"Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, J\u00e4rvinen M (2006) Nationwide decline in incidence of hip fracture. J Bone Miner Res 21:1836\u20131838","journal-title":"J Bone Miner Res"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573\u20131579","journal-title":"JAMA"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2009.1231","volume":"302","author":"WD Leslie","year":"2009","unstructured":"Leslie WD, O\u2019Donnell S, Jean S, Lagac\u00e9 C, Walsh P, Bancej C, Morin S et al (2009) Trends in hip fracture rates in Canada. JAMA 302:883\u2013889","journal-title":"JAMA"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1259\/bjr.75.897.750736","volume":"75","author":"G Holt","year":"2002","unstructured":"Holt G, Khaw KT, Reid DM, Compston JE, Bhalla A, Woolf AD, Crabtree NJ et al (2002) Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50\u00a0years of age: implications for clinical densitometry. Br J Radiol 75:736\u2013742","journal-title":"Br J Radiol"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00198-009-1153-1","volume":"21","author":"E Noon","year":"2010","unstructured":"Noon E, Singh S, Cuzick J, Spector TD, Williams FM, Frost ML, Howell A, Harvie M, Eastell R, Coleman RE, Fogelman I, Blake GM, IBIS-II Bone Substudy (2010) Significant differences in UK and US female bone density reference ranges. Osteoporos Int 21:1871\u20131880","journal-title":"Osteoporos Int"},{"key":"63_CR35","unstructured":"NICE (2008) National Institute for Clinical Excellence (NICE) technology appraisal guidance 160. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. http:\/\/www.nice.org.uk\/TA160 . Accessed 17 November 2010"},{"key":"63_CR36","unstructured":"Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group Case finding for the management of osteoporosis with FRAX\u00ae\u2014Assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395\u20131408. Erratum Osteoporos Int 2009;20:499\u2013502"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C et al (2009) National Osteoporosis Guideline Group (NOGG). Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50\u00a0years in the UK. Maturitas 62:105\u2013108","journal-title":"Maturitas"},{"key":"63_CR38","first-page":"126","volume-title":"Burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2002. The World Health Report 2004: changing history","author":"World Health Organization","year":"2004","unstructured":"World Health Organization (2004) Burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2002. The World Health Report 2004: changing history. World Health Organization, Geneva, pp 126\u2013131"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-011-0063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-011-0063-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-011-0063-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T08:59:42Z","timestamp":1560416382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-011-0063-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11657-011-0063-y","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,26]]}}}